NRSN | NeuroSense Therapeutics Ltd. Annual & Quarterly

Annual Income Statements

(In USD)

Breakdown	2023	2022	2021	2020	2019
Revenue	-	-	-	-	-
Cost of Revenue	97 Thousand	89 Thousand	3000.00	3000.00	-
Gross Profit	-97 Thousand	-89 Thousand	-3000.00	-3000.00	-
Operating Expenses	10.28 Million	13.55 Million	5.58 Million	2.88 Million	1.23 Million
Selling, General and Administrative Expenses	4.77 Million	7.13 Million	2.5 Million	393 Thousand	337 Thousand
Research and Development Expenses	7.27 Million	6.41 Million	3.08 Million	2.49 Million	898 Thousand
Other Expenses	-	-	-	-	-
Cost and Expenses	10.28 Million	13.55 Million	5.58 Million	2.88 Million	1.23 Million
Operating Income	-12.04 Million	-13.55 Million	-5.58 Million	-2.88 Million	-1.23 Million
Interest Expense	550 Thousand	15 Thousand	1.15 Million	1000.00	5000.00
Income Tax Expense	-	-1.14 Million	-1.54 Million	1000.00	5000.00
Earnings before Tax	-11.28 Million	-12.34 Million	-4.04 Million	-2.82 Million	-1.22 Million
Net Income	-10.1 Million	-11.19 Million	-2.49 Million	-2.82 Million	-1.22 Million
Earnings Per Share Basic	-0.83	-0.97	-1.29	-1.46	-0.63
Earnings Per Share Diluted	-0.83	-0.97	-1.29	-1.46	-0.63
Weighted Average Shares Outstanding	13.64 Million	11.5 Million	1.94 Million	1.94 Million	1.94 Million
Weighted Average Shares Outstanding (Diluted)	13.64 Million	11.5 Million	1.94 Million	1.94 Million	1.94 Million
Gross Margin	-	-	-	-	-
EBIT Margin	-	-	-	-	-
Profit Margin	-	-	-	-	-
EBITDA	-10.63 Million	-13.37 Million	-2.88 Million	-2.82 Million	-1.25 Million
Earnings Before Tax Margin	-	-	-	-	-

Breakdown	2024 Q2	2024 Q1	2023 FY	2023 Q4	2023 Q3	2023 Q2
Revenue	-	-	-	-	-	-
Cost of Revenue	-	-	97 Thousand	-	-	-
Gross Profit	-	-	-97 Thousand	-	-	-
Operating Expenses	3.03 Million	2.99 Million	13.2 Million	3.28 Million	2.89 Million	3.47 Million
Selling, General and Administrative Expenses	1.46 Million	1.11 Million	-	1.32 Million	1.27 Million	1.57 Million
Research and Development Expenses	1.56 Million	1.88 Million	-	1.95 Million	1.62 Million	1.9 Million
Other Expenses	-	-	-	-	-	-
Cost and Expenses	3.03 Million	2.99 Million	13.3 Million	3.28 Million	2.89 Million	3.47 Million
Operating Income	-3.03 Million	-2.99 Million	-13.3 Million	-3.28 Million	-2.89 Million	-3.47 Million
Interest Expense	-	2.41 Million	550 Thousand	-2.19 Million	2.2 Million	-304 Thousand
Income Tax Expense	-	-43.27 Thousand	-1.00	-1.00	5.92 Million	-2.17 Million
Earnings before Tax	-857 Thousand	-5.4 Million	-11.28 Million	-2.95 Million	784 Thousand	-5.22 Million
Net Income	-857 Thousand	-5.4 Million	-11.28 Million	-2.95 Million	784 Thousand	-5.22 Million
Earnings Per Share Basic	-0.06	-0.35	-	-0.19	0.06	-0.38
Earnings Per Share Diluted	-0.06	-0.35	-	-0.19	0.06	-0.38
Weighted Average Shares Outstanding	15.4 Million	15.4 Million	13.64 Million	15.37 Million	13.62 Million	13.62 Million
Weighted Average Shares Outstanding (Diluted)	15.4 Million	15.4 Million	13.64 Million	15.37 Million	13.62 Million	13.62 Million
Gross Margin	-	-	-	-	-	-
EBIT Margin	-	-	-	-	-	-
Profit Margin	-	-	-	-	-	-
EBITDA	-3.03 Million	-2.99 Million	-	-5.14 Million	2.98 Million	-5.52 Million
Earnings Before Tax Margin	-	-	-	-	-	-